Bacil Pharma Ltd — Important, 28-05-2026: Company Update

Bacil Pharma submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirmed broad adherence to compliance standards. Stock exchanges had sought clarifications on certain quarterly shareholding patterns due to discrepancies and technical filing issues, and also on financial results not being signed by authorized personnel. Bacil Pharma promptly addressed these observations by filing revised documents and explaining the issues as procedural. The company has since implemented strengthened internal controls to ensure accurate and timely future regulatory filings.